{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRMDN3 (also known as protein tyrosine phosphatase interacting protein 51 or PTPIP51) functions as a versatile scaffold at the interface between the endoplasmic reticulum (ER) and mitochondria. Through its ability to tether these organelles, RMDN3 regulates essential processes such as autophagy, Ca²⁺ transfer, and phospholipid exchange. In doing so, it modulates ER–mitochondria signaling that governs energy production and the initiation of cell death, while also facilitating lipid binding/transfer—which contributes to the maintenance of mitochondrial membrane composition. These interorganelle communications are critical for normal cell physiology and can be disrupted in disease states."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "4"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its role in interorganelle tethering, RMDN3 is a key regulator of programmed cell death and differentiation. Overexpression of RMDN3 has been shown to induce apoptosis via mitochondrial membrane depolarization and cytochrome c release, an effect that depends on the integrity of a transmembrane domain necessary for its mitochondrial targeting. In addition, its tissue‐selective expression—observed in differentiating epithelia, muscle cells, and placental trophoblasts—links RMDN3 to processes that regulate cellular differentiation, cytoskeletal organization, and even angiogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "5", "end_ref": "9"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn pathological contexts, aberrant RMDN3 activity and regulation are implicated in several diseases. Disturbed ER–mitochondria tethering—often resulting from altered phosphorylation states that affect its interactions with proteins such as 14-3-3, c-Src, and Raf-1—has been associated with neurodegenerative conditions like Alzheimer’s disease and amyotrophic lateral sclerosis, where impaired Ca²⁺ signaling compromises synaptic function. Similarly, in various cancers including glioblastoma, acute myeloid leukemia, non-small cell lung cancer, and prostate carcinoma, both upregulation and downregulation of RMDN3 occur. In these settings, its differential interactions with key signaling partners (for instance, via complexes involving PTEN, EGFR, and components of the MAPK cascade) can either promote oncogenic signaling or enforce tumor-suppressive mechanisms."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "18"}]}, {"type": "t", "text": ""}]}]}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Patricia Gomez-Suaga, Sebastien Paillusson, Radu Stoica, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The ER-Mitochondria Tethering Complex VAPB-PTPIP51 Regulates Autophagy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Curr Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cub.2016.12.038"}], "href": "https://doi.org/10.1016/j.cub.2016.12.038"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28132811"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28132811"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Dawn H W Lau, Sebastien Paillusson, Naomi Hartopp, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Disruption of endoplasmic reticulum-mitochondria tethering proteins in post-mortem Alzheimer's disease brain."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2020.105020"}], "href": "https://doi.org/10.1016/j.nbd.2020.105020"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32682953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32682953"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Hyun Ku Yeo, Tae Hyun Park, Hee Yeon Kim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phospholipid transfer function of PTPIP51 at mitochondria-associated ER membranes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embr.202051323"}], "href": "https://doi.org/10.15252/embr.202051323"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33938112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33938112"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Andrea Markovinovic, Sandra M Martín-Guerrero, Gábor M Mórotz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "2+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": " and synaptic defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Acta Neuropathol Commun (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s40478-024-01742-x"}], "href": "https://doi.org/10.1186/s40478-024-01742-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38395965"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38395965"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Albrecht Stenzinger, Tobias Kajosch, Claudia Tag, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel protein PTPIP51 exhibits tissue- and cell-specific expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histochem Cell Biol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00418-004-0732-7"}], "href": "https://doi.org/10.1007/s00418-004-0732-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15609043"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15609043"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "B F Lv, C F Yu, Y Y Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein tyrosine phosphatase interacting protein 51 (PTPIP51) is a novel mitochondria protein with an N-terminal mitochondrial targeting sequence and induces apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Apoptosis (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10495-006-8882-9"}], "href": "https://doi.org/10.1007/s10495-006-8882-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16820967"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16820967"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Albrecht Stenzinger, David Märker, Philipp Koch, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Protein tyrosine phosphatase interacting protein 51 (PTPIP51) mRNA expression and localization and its in vitro interacting partner protein tyrosine phosphatase 1B (PTP1B) in human placenta of the first, second, and third trimester."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Histochem Cytochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1369/jhc.2008.951533"}], "href": "https://doi.org/10.1369/jhc.2008.951533"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18854601"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18854601"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "P Koch, A Stenzinger, M Viard, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1582-4934.2008.00198.x"}], "href": "https://doi.org/10.1111/j.1582-4934.2008.00198.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19012732"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19012732"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Justus Barop, Heinrich Sauer, Klaus Steger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differentiation-dependent PTPIP51 expression in human skeletal muscle cell culture."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Histochem Cytochem (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1369/jhc.2008.952846"}], "href": "https://doi.org/10.1369/jhc.2008.952846"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19124842"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19124842"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Philipp Koch, Meike Petri, Agnieszka Paradowska, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Prostate (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/pros.21025"}], "href": "https://doi.org/10.1002/pros.21025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19691131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19691131"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Alexander Brobeil, Michaela Graf, Sabine Oeschger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51-a myeloid lineage specific protein interacts with PTP1B in neutrophil granulocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood Cells Mol Dis (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcmd.2010.04.009"}], "href": "https://doi.org/10.1016/j.bcmd.2010.04.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20627780"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20627780"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Alexander Brobeil, Manuel Bobrich, Michaela Graf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51 is phosphorylated by Lyn and c-Src kinases lacking dephosphorylation by PTP1B in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leuk Res (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.leukres.2011.03.024"}], "href": "https://doi.org/10.1016/j.leukres.2011.03.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21513978"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21513978"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "M K Petri, P Koch, A Stenzinger, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Histol Histopathol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.14670/HH-26.1531"}], "href": "https://doi.org/10.14670/HH-26.1531"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21972092"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21972092"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Alexander Brobeil, Manuel Bobrich, Claudia Tag, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51 in protein interactions: regulation and in situ interacting partners."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biochem Biophys (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s12013-012-9357-y"}], "href": "https://doi.org/10.1007/s12013-012-9357-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22544307"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22544307"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Alexander Brobeil, Philipp Koch, Moritz Eiber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The known interactome of PTPIP51 in HaCaT cells—inhibition of kinases and receptors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biochem Cell Biol (2014)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24501773"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24501773"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "M K Petri, A Brobeil, J Planz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurooncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11060-015-1763-8"}], "href": "https://doi.org/10.1007/s11060-015-1763-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25862004"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25862004"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Alexander Brobeil, Eric Dietel, Stefan Gattenlöhner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Orchestrating cellular signaling pathways-the cellular \"conductor\" protein tyrosine phosphatase interacting protein 51 (PTPIP51)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Tissue Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00441-016-2508-5"}], "href": "https://doi.org/10.1007/s00441-016-2508-5"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27734150"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27734150"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Minwei He, Xing Wang, Wei Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PTPIP51 inhibits non-small-cell lung cancer by promoting PTEN-mediated EGFR degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2021.120293"}], "href": "https://doi.org/10.1016/j.lfs.2021.120293"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35240162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35240162"}]}]}]}